Please login to the form below

Not currently logged in
Email:
Password:

NICE

This page shows the latest NICE news and features for those working in and with pharma, biotech and healthcare.

NICE backs first cannabis-based drugs, both from GW Pharma

NICE backs first cannabis-based drugs, both from GW Pharma

Updated guidelines from cost-effectiveness watchdog NICE back the use of GW Pharma’s Epidyolex (cannabidiol) for the treatment of seizures in patients with Lennox Gastaut syndrome (LGS) or Dravet syndrome – ... 2014. NICE turned down Epidyolex in 

Latest news

More from news
Approximately 380 fully matching, plus 810 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 11 fully matching, plus 113 partially matching documents found.

Latest appointments

More from appointments
Approximately 3 fully matching, plus 10 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 4 fully matching, plus 46 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Oxford University Press

Oxford University Press publishes over 100 prestigious, highly cited, and authoritative medical journals, many in collaboration with some of the...

Latest intelligence

APAC map
Pharmaceutical innovation in the APAC region
A first-of-its-kind study paints a vivid picture of the APAC region’s future...
Patient journey mapping: exploring the clinical and the emotional journey
By Chris Hodgson, Neil Rees, Sumira Riaz and Karen Petticrew While we can all agree that the value of developing a patient journey map cannot be underestimated when exploring the...
Precision medicine at Blue Latitude Health
At Blue Latitude Health we have identified 90+ insights about commercialising precision medicines. Check out our video to get a run down on three core components of the commercialisation and...

Infographics